Home » Topics » Regulatory

Regulatory
RSS

Zindaclin receives further E.U. approvals

Jan. 7, 2003

Humira approved by FDA for RA

Jan. 3, 2003

Foradil Certihaler filed for approval in the U.S.

Jan. 3, 2003

Novartis files supplemental NDA for Starlix

Jan. 3, 2003

Olux approved for treatment of psoriasis

Jan. 3, 2003

Cephalon files sNDA for Provigil

Jan. 3, 2003

Casodex 150 mg not recommended for use in U.S. in early prostate cancer

Jan. 2, 2003

E.U. approval obtained for once-weekly Actonel/Optinate for postmenopausal osteoporosis

Jan. 2, 2003

Once-daily Depakote ER approved for certain forms of epilepsy

Jan. 2, 2003

FDA approval for Xalatan as first-line therapy for elevated IOP

Jan. 2, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Hits’ Hyperlab launches as ‘virtual AI lab’ for new drug discovery
BioWorld Science
Things once done in laboratories can now be done with computers and AI, said Kim Woo-youn, CEO and cofounder of Hits Inc. “We live in the age of ‘digital...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...